{"id":"https://openalex.org/W2319216644","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.8531","title":"Activity of cabozantinib (XL184) in metastatic melanoma: Results from a phase II randomized discontinuation trial (RDT).","display_name":"Activity of cabozantinib (XL184) in metastatic melanoma: Results from a phase II randomized discontinuation trial (RDT).","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2319216644","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.8531","mag":"2319216644"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.8531","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.8531","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.8531","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069690249","display_name":"Michael S. Gordon","orcid":"https://orcid.org/0000-0002-7679-9504","observed_orcids":["https://orcid.org/0000-0002-7679-9504"]},"institutions":[{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael S. Gordon","raw_affiliation_strings":["Pinnacle Oncology Hematology, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pinnacle Oncology Hematology, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001175430","display_name":"Harriet M. Kluger","orcid":"https://orcid.org/0000-0002-4932-9873","observed_orcids":["https://orcid.org/0000-0002-4932-9873"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harriet M. Kluger","raw_affiliation_strings":["Yale Cancer Center, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, New Haven, CT","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Shapiro","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["University of Texas M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111917213","display_name":"Gerald M. Edelman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald Edelman","raw_affiliation_strings":["Texas Oncology, Irving, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology, Irving, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013992684","display_name":"Thomas A. Samuel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas A. Samuel","raw_affiliation_strings":["Georgia Health Sciences University, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Health Sciences University, Augusta, GA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078237755","display_name":"Ali H. Moussa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ali H. Moussa","raw_affiliation_strings":["Cancer Care Associates, Tulsa, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Care Associates, Tulsa, OK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031968057","display_name":"David Albert Ramies","orcid":"https://orcid.org/0009-0007-3223-648X","observed_orcids":["https://orcid.org/0009-0007-3223-648X"]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Ramies","raw_affiliation_strings":["Exelixis, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087379820","display_name":"Alexander Laird","orcid":"https://orcid.org/0000-0002-7296-025X","observed_orcids":["https://orcid.org/0000-0002-7296-025X"]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Douglas Laird","raw_affiliation_strings":["Exelixis, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054043060","display_name":"Frauke Schimm\u00f6ller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frauke Schimmoller","raw_affiliation_strings":["Exelixis, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086309026","display_name":"Xiaodong Shen","orcid":"https://orcid.org/0000-0001-8570-8566","observed_orcids":["https://orcid.org/0000-0001-8570-8566","https://orcid.org/0000-0002-6741-0667","https://orcid.org/0009-0007-0326-6671","https://orcid.org/0000-0002-8671-9758"]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaodong Shen","raw_affiliation_strings":["Exelixis, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018322482","display_name":"ADIL I. DAUD","orcid":"https://orcid.org/0000-0002-6617-8421","observed_orcids":["https://orcid.org/0000-0002-6617-8421"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adil Daud","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"8531","last_page":"8531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.6601999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.6601999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.1876000016927719,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.026000000536441803,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/ocular-melanoma","display_name":"ocular melanoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/met-inhibition","display_name":"MET inhibition","score":0.7910000085830688},{"id":"https://openalex.org/keywords/vegfr-2-inhibition","display_name":"VEGFR-2 inhibition","score":0.9919999837875366},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7170000076293945},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.4000000059604645},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.47999998927116394},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.5090000033378601},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.5350000262260437},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.656000018119812},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.39899998903274536},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.4000000059604645},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.931623637676239},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.8842077255249023},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6369337439537048},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6260040402412415},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6152957677841187},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5415734052658081},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5238552093505859},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4698342978954315},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.44381770491600037},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4343174397945404},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42555394768714905},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.42539867758750916},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42478105425834656},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3695168197154999},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.18492141366004944},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.8531","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.8531","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.8531","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2575667551","https://openalex.org/W2188135389","https://openalex.org/W2468601751","https://openalex.org/W2798901554","https://openalex.org/W2469095888","https://openalex.org/W2528809664","https://openalex.org/W2562023344","https://openalex.org/W2315499684","https://openalex.org/W2739361661","https://openalex.org/W1989576302"],"abstract_inverted_index":{"8531":[0],"Background:":[1],"MET":[2,21],"and":[3,11,22,28,102,142,287,298,326,331],"VEGF":[4],"signaling":[5],"are":[6,130],"implicated":[7],"in":[8,30,109,240,308,321],"angiogenesis,":[9],"invasion,":[10],"metastasis.":[12],"Cabozantinib":[13],"(cabo)":[14],"is":[15,123,231],"an":[16],"oral,":[17],"potent":[18],"inhibitor":[19],"of":[20,163,225,234,265,295,313,329,338,344],"VEGFR2.":[23],"A":[24],"RDT":[25],"evaluated":[26],"activity":[27,307],"safety":[29,336],"9":[31],"tumor":[32,236,248,333],"types.":[33],"Here":[34],"we":[35],"report":[36],"on":[37,85],"the":[38,43,110,181],"metastatic":[39,309],"melanoma":[40,138,310],"cohort,":[41],"including":[42,250],"ocular":[44,143,255],"subtype.":[45],"Methods:":[46],"Eligible":[47],"patients":[48],"(pts)":[49],"were":[50,96,280],"required":[51],"to":[52,98,120,189,194,324,342],"have":[53],"progressive":[54],"measurable":[55],"disease":[56],"per":[57],"RECIST.":[58],"Pts":[59],"received":[60],"cabo":[61,99,191,205,339],"at":[62,227,268],"100":[63],"mg":[64],"qd":[65],"over":[66],"a":[67],"12":[68,82],"wk":[69,81,269],"Lead-in":[70,183,302],"stage.":[71,303],"Tumor":[72],"response":[73],"(mRECIST)":[74],"was":[75,83,113,170,201,220,238,340],"assessed":[76],"q6":[77],"wks.":[78],"Treatment":[79],"\u2265":[80,150,245],"based":[84],"response:":[86],"pts":[87,93,103,129,178,187,242,252,261],"with":[88,94,104,185,244,254,319],"PR":[89],"continued":[90],"open-label":[91,182],"cabo,":[92],"SD":[95],"randomized":[97,111,188],"vs":[100],"placebo,":[101,325],"PD":[105],"discontinued.":[106],"Primary":[107],"endpoint":[108],"phase":[112],"progression":[114],"free":[115],"survival":[116],"(PFS).":[117],"Results:":[118],"Enrollment":[119],"this":[121],"cohort":[122],"complete":[124],"(n":[125],"=":[126],"77);":[127],"all":[128],"unblinded.":[131],"Baseline":[132],"characteristics:":[133],"median":[134,160],"age":[135],"66":[136],"years;":[137],"subtype:":[139],"cutaneous/mucosal":[140],"70%":[141],"30%;":[144],"known":[145],"BRAF":[146,316],"mutation":[147,317],"32%;":[148],"LDH":[149],"1.1":[151],"x":[152],"upper":[153],"limit":[154],"normal":[155],"35%;":[156],"bone":[157,258,266],"metastases":[158],"19%;":[159],"prior":[161],"lines":[162],"therapy":[164],"1":[165,219,246],"(range":[166,173],"0-5).":[167],"Median":[168,197,214],"follow-up":[169],"2.8":[171],"months":[172,203,208],"0.3":[174],"-":[175],"25).":[176],"35":[177],"(45%)":[179],"completed":[180],"stage":[184],"25":[186],"continue":[190],"(n=12)":[192],"or":[193,315],"placebo":[195,210],"(n=13).":[196],"PFS":[198,215,226,322],"from":[199,216],"randomization":[200],"5.7":[202],"for":[204,209],"vs.":[206],"3":[207],"(HR=0.3,":[211],"p":[212],"=0.055).":[213],"Study":[217],"Day":[218],"4.4":[221],"months.":[222],"The":[223,335],"estimate":[224],"month":[228],"6":[229,270],"(PFS6)":[230],"44%.":[232],"Evidence":[233],"objective":[235,332],"regression":[237],"observed":[239],"39/65":[241],"(60%)":[243],"post-baseline":[247],"assessment":[249],"11/23":[251],"(48%)":[253],"melanoma.":[256],"Two":[257],"scan":[259],"evaluable":[260],"demonstrated":[262],"partial":[263],"resolution":[264],"lesions":[267],"accompanied":[271],"by":[272],"pain":[273],"relief.":[274],"Most":[275],"common":[276],"Grade":[277,292],"3/4":[278],"AEs":[279],"fatigue":[281],"(14%),":[282],"HTN":[283],"(9%),":[284],"constipation":[285],"(4%),":[286],"diarrhea":[288],"(3%);":[289],"one":[290],"related":[291],"5":[293],"AE":[294],"diverticular":[296],"perforation":[297],"peritonitis":[299],"reported":[300],"during":[301],"Conclusions:":[304],"Cabo":[305],"demonstrates":[306],"pts,":[311],"regardless":[312],"subtypes":[314],"status,":[318],"improvement":[320],"relative":[323],"high":[327],"rates":[328],"PFS6":[330],"regression.":[334],"profile":[337],"comparable":[341],"that":[343],"other":[345],"VEGFR":[346],"TKIs.":[347]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}